Stockholders' equity

9 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Stockholders' equity

Stockholders’ equity

“At the market” common stock offering program

During the nine months ended September 30, 2015, we sold an aggregate of 56,874 shares of common stock for gross proceeds of $5.3 million at an average stock price of $94.02 and net proceeds of approximately $5.1 million, including commissions and other expenses of approximately $295 thousand.

Dividends

In September 2015, we declared cash dividends on our common stock for the third quarter of 2015, aggregating $55.8 million, or $0.77 per share. Also in September 2015, we declared cash dividends on our Series D Convertible Preferred Stock for the third quarter of 2015, aggregating approximately $4.2 million, or $0.4375 per share. Additionally, we declared cash dividends on our Series E cumulative redeemable preferred stock (“Series E Preferred Stock”) for the third quarter of 2015, aggregating approximately $2.1 million, or $0.403125 per share. In October 2015, we paid the cash dividends on our common stock, Series D Preferred Stock, and Series E Preferred Stock for the third quarter of 2015.

Accumulated other comprehensive income (loss)

Accumulated other comprehensive income (loss) attributable to Alexandria consists of the following (in thousands):

	Unrealized Gains on Marketable Securities			Unrealized Losses on Interest Rate Swap Agreements			Unrealized Losses on Foreign Currency Translation			Total
Balance as of December 31, 2014	$	52,367		$	(909	)	$	(52,086	)	$	(628	)
Other comprehensive income (loss) before reclassifications	54,004			(9,712		)	(17,072		)	27,220
Amounts reclassified from other comprehensive (loss) income	(2,503		)	1,942			9,236			8,675
	51,501			(7,770		)	(7,836		)	35,895
Amounts attributable to noncontrolling interest	—			—			(29		)	(29		)
Net other comprehensive income (loss)	51,501			(7,770		)	(7,865		)	35,866
Balance as of September 30, 2015	$	103,868		$	(8,679	)	$	(59,951	)	$	35,238

Preferred stock and excess stock authorizations

Our charter authorizes the issuance of up to 100.0 million shares of preferred stock, of which 14.7 million shares were issued and outstanding as of September 30, 2015. In addition, 200.0 million shares of “excess stock” (as defined in our charter) are authorized, none of which were issued and outstanding as of September 30, 2015.